Top Markets
Coin of the day
WayPoint Biomedical Holdings, Inc. WayPoint Biomedical Holdings, Inc.

WayPoint Biomedical Holdings, Inc.

WYPH
Classifica tra le azioni #41072
WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary,... WayPoint Biomedical Holdings, Inc., through its wholly owned subsidiary, WayPoint Biomedical, Inc., engages in the development and marketing of diagnostic tests and devices for screening and monitoring human health, fitness, and environment. It offers a drink spiking test, the Drink Detective, used to detect date rape drugs, including Ketamine, GHB, and Benzodiazapines; and Health Essist tests for cocaine and marijuana detection. The company also develops and commercializes test kits for detection against possible explosive devices, biowarfare/bioterrorism agents, and the detection of weapons of mass destruction. In addition, it provides Frontline Explosive Test Kit for the detection of explosive residues. The company offers its products to the over-the-counter diagnostic self-testing, the diagnostic point of care, and the homeland security and defense markets. WayPoint Biomedical Holdings was founded in 2004 and is based in Huntington Beach, California.
Prezzo delle azioni
$0.0005
Ultima sincronizzazione: 2026-08-12
Capitalizzazione di mercato
$16.62K
Variazione (1 giorno)
-64.29%
Variazione (1 anno)
400.00%
Paese
US
Scambia WayPoint Biomedical Holdings, Inc. (WYPH)

Categoria

Rapporto P/S per WayPoint Biomedical Holdings, Inc. (WYPH)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di WayPoint Biomedical Holdings, Inc., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per WayPoint Biomedical Holdings, Inc. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
7.27 -
US
- -
CA
5.81 -
US
2.61 -
AU
4.33 -
US